Company Tagline
We are a biotechnology company developing novel, multi-pathway modulators for cancer and fibrosis
Industry Category
Business Keywords
Company Description
NovoMedix is a dynamic biotechnology company dedicated to pioneering innovative therapies for cancer and fibrosis. Located at 7966 Arjons Drive, Suite D, San Diego, California 92126-6361, US, NovoMedix focuses on the development of novel, multi-pathway modulators designed to address critical unmet needs in these challenging disease areas.
With a strong emphasis on small molecule drug discovery and IL-11 inhibitors, NovoMedix is committed to advancing cutting-edge research that has the potential to transform patient outcomes. The company's work extends to cardioprotection, reflecting a broad and forward-thinking approach to therapeutic innovation. NovoMedix aims to create significant advancements in the biotechnology field.
NovoMedix is poised for continued growth and success in the biotechnology sector, driven by its commitment to scientific excellence and its dedication to improving the lives of patients. We invite the manager of NovoMedix to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking work.
NovoMedix est une entreprise de biotechnologie dynamique dédiée à la création de thérapies innovantes pour le cancer et la fibrose. Située au 7966 Arjons Drive, Suite D, San Diego, Californie 92126-6361, États-Unis, NovoMedix se concentre sur le développement de modulateurs multi-voies novateurs conçus pour répondre aux besoins critiques non satisfaits dans ces domaines pathologiques difficiles.
Avec un fort accent sur la découverte de médicaments à petites molécules et les inhibiteurs de l'IL-11, NovoMedix s'engage à faire progresser la recherche de pointe susceptible de transformer les résultats pour les patients. Les travaux de l'entreprise s'étendent à la cardioprotection, reflétant une approche large et avant-gardiste de l'innovation thérapeutique. NovoMedix vise à réaliser des avancées significatives dans le domaine de la biotechnologie.
NovoMedix est prête pour une croissance et un succès continus dans le secteur de la biotechnologie, grâce à son engagement envers l'excellence scientifique et son dévouement à l'amélioration de la vie des patients. Nous invitons le responsable de NovoMedix à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin de mettre davantage en évidence son travail novateur.
Key Personnel / Employees
Compare Companies Side by Side
Compare NovoMedix with 3 companies in Biotechnology-Research
| Comparison Field |
NovoMedixMain Company |
Al
Alentis TherapeuticsView Profile |
Tvardi TherapeuticsView Profile |
Newcastle Fibrosis R...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2019 | 2017 | 2010 |
|
Company Size
|
— | 51-200 | 2-10 | 11-50 |
|
City
|
San Diego, California | Allschwil, Basel-Country | Houston, TX | Newcastle Upon Tyne, Newcastle |
|
Country
|
United States | Switzerland | United States | United Kingdom |
|
Skills & Keywords
Comparing with main company
|
10 Total Skills
Biotechnology
Drug Discovery
IL-11 Inhibitors
Cancer Research
Fibrosis Treatment
Cardioprotection
Pharmaceuticals
Small molecule drug discovery
Cancer
Fibrosis
|
20 Total
1 Common
19 Unique
Match
10%
Common Skills:
Drug Discovery
Unique Skills:
ADC
ALE.C04
ALE.F02
ANCA-associated vasculitis
Antibody-drug conjugates
Claudin
+13
|
3 Total
3 Unique
Unique Skills:
Inflammation
Small Molecules
STAT3
|
9 Total
9 Unique
Unique Skills:
Academic research
Chronic liver diseases
Drug discovery
Epigenetics
Industrial collaborations
Lung Fribrosis
+3
|
4
Total Companies2010
Oldest Founded3
Countries41
Unique SkillsSimilar Companies
Other organizations in the same industry
MilaK
Biotechnology-ResearchMilaK performance supplements, using biotechnology to create functional food.
Mycorrhizal Applications
Biotechnology-ResearchThe world's leading researchers, developers, and manufacturers of mycorrhizal inoculant products sin...
1910
Biotechnology-ResearchAI-native biotech building a Multimodal AI Platform for Modality Agnostic Drug Discovery™
Alternative Company Names
This company is also known as